PLCH2
Basic information
Region (hg38): 1:2425980-2505532
Previous symbols: [ "PLCL4" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLCH2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 17 | |||||
missense | 125 | 14 | 142 | |||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 1 | 4 | |||
non coding | 4 | |||||
Total | 0 | 0 | 126 | 24 | 15 |
Variants in PLCH2
This is a list of pathogenic ClinVar variants found in the PLCH2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-2476595-G-T | not specified | Uncertain significance (Sep 14, 2022) | ||
1-2476603-G-A | See cases | Uncertain significance (Sep 13, 2019) | ||
1-2476606-C-T | Benign (Jul 31, 2018) | |||
1-2476610-C-T | not specified | Uncertain significance (Apr 19, 2023) | ||
1-2476619-C-T | not specified | Uncertain significance (Oct 06, 2021) | ||
1-2476620-G-A | not specified | Uncertain significance (Jul 16, 2024) | ||
1-2476632-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
1-2476647-C-T | not specified | Uncertain significance (Sep 14, 2023) | ||
1-2476671-G-C | Benign (Jan 12, 2018) | |||
1-2476673-A-T | not specified | Uncertain significance (Jul 16, 2024) | ||
1-2476706-C-G | not specified | Uncertain significance (Jul 20, 2021) | ||
1-2478526-C-T | not specified | Uncertain significance (Aug 22, 2023) | ||
1-2478527-G-A | not specified | Uncertain significance (Sep 12, 2023) | ||
1-2478571-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
1-2479739-A-G | not specified | Uncertain significance (Oct 26, 2022) | ||
1-2479770-G-A | not specified | Uncertain significance (Nov 24, 2024) | ||
1-2479811-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
1-2479840-C-T | Benign (Dec 31, 2019) | |||
1-2479841-G-A | not specified | Uncertain significance (Mar 25, 2024) | ||
1-2479850-C-T | not specified | Uncertain significance (Nov 07, 2024) | ||
1-2479853-G-A | not specified | Uncertain significance (Aug 01, 2024) | ||
1-2479855-G-T | not specified | Uncertain significance (Jul 08, 2022) | ||
1-2479857-C-T | not specified | Uncertain significance (Jul 27, 2024) | ||
1-2479913-C-T | not specified | Uncertain significance (Sep 20, 2024) | ||
1-2479914-G-A | not specified | Uncertain significance (Oct 17, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PLCH2 | protein_coding | protein_coding | ENST00000449969 | 22 | 79551 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.81e-18 | 0.487 | 124841 | 0 | 64 | 124905 | 0.000256 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.23 | 615 | 707 | 0.869 | 0.0000471 | 7339 |
Missense in Polyphen | 227 | 303.28 | 0.74848 | 3100 | ||
Synonymous | -1.50 | 331 | 298 | 1.11 | 0.0000218 | 2205 |
Loss of Function | 1.80 | 35 | 48.6 | 0.721 | 0.00000236 | 559 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000413 | 0.000408 |
Ashkenazi Jewish | 0.000205 | 0.000199 |
East Asian | 0.00101 | 0.00100 |
Finnish | 0.0000465 | 0.0000464 |
European (Non-Finnish) | 0.000266 | 0.000256 |
Middle Eastern | 0.00101 | 0.00100 |
South Asian | 0.000165 | 0.000163 |
Other | 0.000169 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes. This phospholipase activity is very sensitive to calcium. May be important for formation and maintenance of the neuronal network in the postnatal brain (By similarity). {ECO:0000250}.;
- Pathway
- Inositol phosphate metabolism - Homo sapiens (human);Proton Pump Inhibitor Pathway, Pharmacodynamics;D-<i>myo</i>-inositol (1,4,5)-trisphosphate biosynthesis;Metabolism;phospholipases;D-<i>myo</i>-inositol-5-phosphate metabolism;superpathway of inositol phosphate compounds;Phosphatidylinositol phosphate metabolism;Synthesis of IP3 and IP4 in the cytosol;Inositol phosphate metabolism
(Consensus)
Recessive Scores
- pRec
- 0.101
Haploinsufficiency Scores
- pHI
- 0.167
- hipred
- Y
- hipred_score
- 0.540
- ghis
- 0.601
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.394
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Plch2
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- biological_process;lipid catabolic process;inositol trisphosphate biosynthetic process;intracellular signal transduction;inositol phosphate metabolic process;phosphatidylinositol metabolic process;phosphatidylinositol-mediated signaling;release of sequestered calcium ion into cytosol
- Cellular component
- cellular_component;cytoplasm;plasma membrane
- Molecular function
- molecular_function;phosphatidylinositol phospholipase C activity;calcium ion binding